| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2017-07-07 | ARGX-111 | 1b | arGEN-X (The Netherlands - Belgium) | Cancer - Oncology | |
| 2017-07-07 | JX-594/TG6006 (Pexa-Vec -pexastimogene devacirepvec) and cyclophosphamide | soft tissue sarcoma (STS), HER2 negative-breast cancer | 1-2 | Institut Bergonié (France) Transgene (France) | Cancer - Oncology |
| 2017-07-06 | SHP654 (BAX 888) | hemophilia A | 2 | Shire (UK - USA) | Rare diseases - Genetic diseases - Hematological diseases |
| 2017-07-06 | dMAb® product for flu | flu | preclinical | Inovio Pharmaceuticals (USA - PA) | Infectious diseases |
| 2017-07-05 | |||||
| 2017-07-05 | AR101 | peanut allergy | 3 | Aimmune Therapeutics (USA - CA) previously Allergen Research Corporation (ARC) | Allergic diseases |
| 2017-07-05 | PRS-080 | Functional Iron Deficiency anemia | 2a | Pieris (Germany) | Hematological diseases - Metabolic diseases |
| 2017-07-05 | pembrolizumab (MK-3475) and pomalidomide | multiple myeloma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2017-07-05 | pembrolizumab (MK-3475) | multiple myeloma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2017-07-05 | BGB-3111 | B-cell malignancies | 1 | BeiGene (China) | Cancer - Oncology |
| 2017-07-05 | AsiDNA™ | preclinical | Onxeo (France) | Cancer - Oncology | |
| 2017-07-05 | AM-111 | idiopathic sudden sensorineural hearing loss | 3 | Auris Medical (Switzerland) | Otorhinolaryngology |
| 2017-07-03 | vilaprisan (BAY1002670) | symptomatic uterine fibroids | 3 | Bayer Healthcare (Germany) | Gynecology - Women's health |
| 2017-07-03 | dasiglucagon (ZP4207) | severe hypoglycemia in type 1 diabetes patients | 3 | Zealand Pharma (Denmark) | Metabolic diseases |
| 2017-07-01 | risdiplam - RO7034067/RG7916 | type 2 and type 3 spinal muscular atrophy (SMA) | 2 | PTC Therapeutics (USA - NJ) Roche (Switzerland) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2017-06-29 | SD-809 - deutetrabenazine | tardive dyskinesia | 3 | Teva Pharmaceutical Industries (Israel) | Neurological diseases - CNS diseases |
| 2017-06-28 | gemcabene (CI-1027) | homozygous familial hypercholesterolemia (HoFH) | 2b | Gemphire Therapeutics (USA - Mich) | Rare diseases - Genetic diseases - Cardiovascular diseases |
| 2017-06-28 | remimazolam | procedural sedation in patients undergoing bronchoscopy | 3 | Paion (Germany) | CNS diseases |
| 2017-06-28 | CX-2009 | advanced solid tumors including non-small cell lung cancer, breast cancer, ovarian cancer, endometrial cancer, cholangiocarcinoma (bile duct cancer), head and neck cancer and castration-resistant prostate cancer | 1-2 | CytomX Therapeutics (USA - CA) | Cancer - Oncology |
| 2017-06-27 | MVT-1075 (177Lu-CHX-A-DTPA-HuMab5B1) | recurrent pancreatic cancer and other CA19-9 positive malignancies | 1 | MabVax Therapeutics (USA - CA) | Cancer - Oncology |
